Brief: Lipidor: Positive Results For Development Of Medical Cannabis Products Based On Akvano Technology

Lipidor AB

30/09/2020 07:11

Sept 30 (Reuters) - Lipidor AB  LIPI.ST :
    * LIPIDOR ANNOUNCES POSITIVE OUTCOME OF FEASIBILITY STUDY
FOR
DEVELOPMENT OF TOPICAL MEDICAL CANNABIS PRODUCTS BASED ON THE
COMPANY'S AKVANO® TECHNOLOGY
    * STUDY WAS CONDUCTED IN COLLABORATION WITH CANNASSURE
THERAPEUTICS LTD
    * CANNASSURE ANNOUNCED THAT IT INTENDS TO EXERCISE ITS
OPTION AND
BEGIN NEGOTIATION OF AN EXCLUSIVE LICENSING AGREEMENT FOR USE OF
AKVANO®
    * ACCORDING TO CANNASSURE, BASED ON THESE RESULTS, COMPANY
WILL GO
AHEAD, ACCELERATING PACE OF DEVELOPMENT STEPS AND CONDUCTING
MORE ADVANCED TESTING
    * GOAL IS TO INTRODUCE INNOVATIVE TOPICAL TREATMENTS TO
FAST-GROWING GLOBAL MARKET FOR MEDICAL CANNABIS PRODUCTS

Source text for Eikon:  ID:nWkrc1bjBl 
Further company coverage:  LIPI.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))